---

Background and Objective: Tumor size results in hypoxic and acidic environment leading to the production of several types of growth factors required for the formation of blood vessels. Afterwards, metastasis of cancerous cells occurs via blood vessels. Therefore angiogenesis inhibition can be a new way of cancer treatment. This study was done to determine the bioinformatics analysis to predict potential Micro-RNAs inhibiting processes of angiogenesis in cancer.

Methods: In this descriptive study, micro-RNAs that are able to connect to MMP genes involved in tumor angiogenesis (MMP1-2-3-8-9-10-11-13) were detected using miRwalk database. Effective Micro-RNAs selection was based on the number of binding sites in 3'UTR genes. MicroRNA data base was used to find sample base pairing sequences.

Results: mir-1302, mir-516a, mir-512, mir-511, mir-516b and mir-548 were determined with the most number of binding sites in genes involved in angiogenesis.

Conclusion: MicroRNAs are worthy options for cell culture and laboratory examination in order to find new ways to prevent the development of cancer by angiogenesis inhibition.

---

Background and Objective: Angiogenesis and expression of angiogenic factors in tumor are associated with increased risk of metastasis and reduction of treatment outcomes. This study was performed to evaluate the effect of endurance training on the angiogenic factors (VEGFR-2, VEGF) of tumor in breast cancer bearing mice.
Methods: In this experimental study, 20 BALB/c mice following breast cancer induction were randomly allocated into two groups of experimental (n=10) and control (n=10). Breast cancer tumors were induced by MC4-L2 cell infusion. Animals in the experimental group were received endurance training for 6 weeks, 5 days a week with gradual increase in intensity from 12 to 20 (m.min-1) and duration from 25 to 55 minutes. Tumor volume was measured weekly with digital caliper. Expression of two angiogenic proteins of VEGFR-2 and VEGF were measured by ELISA method.
Results: Endurance training significantly reduced VEGFR-2 protein in training group (1.524±0.324 ng ml^-1) compared to the control group (2.686±0.815 ng ml^-1) (p<0.05), whereas, there was no significant difference in the VEGF protein in the training group (734.633±110.131 pg ml^-1) compared to the control group (756.317±72.32 pg ml^-1). The tumor volume significantly decreased in the training group compared to the control group (p<0.05).
Conclusion: Regular endurance training induces anti-angiogenic effects in tumor tissue of breast cancer bearing mice.

---

Background and Objective: Ovarian cancer, also known as “The Silent Killer,” is one of the most dangerous cancers for women, which often diagnosed late and incurable. On the other hand, conventional therapies currently have limitations, failures and various side effects. This study was performed to determine the effect of pomegranate peel extract on the expression of angiogenesis stimulating gene (Vascular Endothelial Growth Factor: VEGF) by culturing A2780 cell line of ovarian cancer.
Methods: In this descriptive-analytical study, pomegranate peel extract was prepared and then ovarian cancer cells (A2780 cell line) were exposed to different concentrations of pomegranate peel extract (500, 250, 100, 75, 50, 25 and 10 µg/ml) for 48, 24 and 72 hours. Also, the survival rate of the cells was tested by MTT assay and VEGF gene expression was evaluated using RT-PCR.
Results: Pomegranate peel extract concentration of 500 µg/ml reduced the survival rate to 18% in 72 hours (P<0.05). At concentrations of 200, 100 and 50 µg/ml of pomegranate peel extract, the expression of VEGF reduced by 7%, 16% and 19%, respectively, which was significant compared to the control group (P<0.05).
Conclusion: Pomegranate peel extract, due to its numerous compounds and significant antioxidant properties, is likely to reduce metastasis and malignant manifestations by reducing the expression of the angiogenesis agent.

---

Background and Objective: Cancer can spread to distant parts of the body through the lymphatic system or bloodstream. Angiogenesis is a fundamental step in the transition of tumors from a dormant state to a malignant. Some changes in cancerous cells can be improved and treated using herbal extracts. Salvia species in Iranian traditional medicine were used against various infections, inflammatory diseases.This study was done to evaluate the effect of aqueous extract of Salvia atropatana leaf on subcutaneous tumor model of CT26 colon carcinoma in Mice.
Methods: In this experimental study, for the induction of colon carcinoma, 26CT cells were injected into 18 BALB/c male Mice. Subcutaneous injection was done in the right side of the animal. When the size of the tumor was 50±350 mm3, 18 Mice were randomly allocated into 3 groups, including controls, aqueous extracts a breakdown of each dose 50 and 100 mg/kg/bw. The group containing the aqueous extracts of Salvia atropatana leaf was injected for 14 days, daily. To monitor the therapeutic effects, the parameters of the stopping rate in the growth of the tumor, the relative volume changes and the doubling of tumor volume were evaluated. After sacrificed the animals at the end the fourteenth day of the study, tumors were dissected for histological study.
Results: The volume of tumors and the mean density of the number of vessels was significantly reduced in treated group 1 (50 mg/kg/bw of aqueous extracts of Salvia atropatana leaf) and treated group 2 (100 mg/kg/bw of aqueous extracts of Salvia atropatana leaf) in compared to control group (P<0.05). Reduction in density of cells and vascular sections was significantly reduced in treated group 1 (50 mg/kg/bw of aqueous extracts of Salvia atropatana leaf) and treated group 2 (100 mg/kg/bw of aqueous extracts of Salvia atropatana leaf) in compared to control group (P<0.05).
Conclusion: Aqueous extracts of Salvia atropatana leaf has anti-angiogenesis activity and significant inhibitory effects on tumor growth in animal model.